Human papillomavirus vaccination at a time of changing sexual behavior

Emerging Infectious Diseases

Volumn 22, Issue 1, 2016, Pages 18-23

  Baussano, Iacopo ^a   Lazzarato, Fulvio ^a,b,c   Brisson, Marc ^d,e,f   Franceschi, Silvia ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d University Laval   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ARTICLE; CHILD; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PAPILLOMAVIRUS INFECTION; SEXUAL BEHAVIOR; SEXUALITY; VACCINATION; VIRAL CLEARANCE; WART VIRUS; ADOLESCENT; AGED; IMMUNIZATION; IMMUNOLOGY; INDIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYSIOLOGY; PREVALENCE; PROCEDURES; RISK FACTOR; RURAL POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; IMMUNIZATION; INDIA; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RISK FACTORS; RURAL POPULATION; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VACCINATION; YOUNG ADULT;

EID: 84950240745     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2201.150791     Document Type: Article

References (31)

1. Tucker JD, Chen XS, Peeling RW. Syphilis and social upheaval in China. N Engl J Med. 2010;362:1658–61. http://dx.doi.org/10.1056/NEJMp0911149
2. Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, et al. Syphilis in China: results of a national surveillance programme. Lancet. 2007;369:132–8.http://dx.doi.org/10.1016/S0140-6736(07)60074-9
3. Wellings K, Collumbien M, Slaymaker E, Singh S, Hodges Z, Patel D, et al. Sexual behaviour in context: a global perspective. Lancet. 2006;368:1706–28.http://dx.doi.org/10.1016/S0140-6736(06)69479-8
4. Mercer CH, Tanton C, Prah P, Erens B, Sonnenberg P, Clifton S, et al. Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382: 1781–94.http://dx.doi.org/10.1016/S0140-6736(13)62035-8
5. Gregson S, Nyamukapa CA, Garnett GP, Mason PR, Zhuwau T, Carael M, et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet. 2002;359:1896–903.http://dx.doi.org/10.1016/S0140-6736(02)08780-9
6. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, et al.; IARC HPV Prevalence Surveys Study Group. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer. 2006;119:2677–84. http://dx.doi.org/10.1002/ijc.22241
7. Baussano I, Elfstrom KM, Lazzarato F, Gillio-Tos A, De Marco L, Carozzi F, et al. Type-specific human papillomavirus biological features: validated model-based estimates. PLoS ONE. 2013;8:e81171. http://dx.doi.org/10.1371/journal.pone.0081171
8. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349–59. http://dx.doi.org/10.1002/ijc.27485
9. Lopman B, Nyamukapa C, Mushati P, Mupambireyi Z, Mason P, Garnett GP, et al. HIV incidence in 3 years of follow-up of a Zimbabwe cohort—1998–2000 to 2001–03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol. 2008;37:88–105. http://dx.doi.org/10.1093/ije/dym255
10. Baggaley RF, Garnett GP, Ferguson NM. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med. 2006;3:e124. http://dx.doi.org/10.1371/journal.pmed.0030124
11. Garnett GP, Anderson RM. Balancing sexual partnerships in an age and activity stratified model of HIV transmission in heterosexual populations. IMA J Math Appl Med Biol. 1994;11:161–92. http://dx.doi.org/10.1093/imammb/11.3.161
12. Vänskä S, Auranen K, Leino T, Salo H, Nieminen P, Kilpi T, et al. Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach. PLoS ONE. 2013;8:e72088. http://dx.doi.org/10.1371/journal.pone.0072088
13. Johnson HC, Elfstrom KM, Edmunds WJ. Inference of typespecific HPV transmissibility, progression and clearance rates: a mathematical modelling approach. PLoS ONE. 2012;7:e49614. http://dx.doi.org/10.1371/journal.pone.0049614
14. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med. 2006;3:e138. http://dx.doi.org/10.1371/journal.pmed.0030138
15. Van de Velde N, Brisson M, Boily MC. Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis. Vaccine. 2010;28:5473–84. http://dx.doi.org/10.1016/j.vaccine.2010.05.056
16. Hertog S. Heterosexual behavior patterns and the spread of HIV/AIDS: the interacting effects of rate of partner change and sexual mixing. Sex Transm Dis. 2007;34:820–8.
17. Demographic and Health Survey Program. India: standard DHS, 2005–06. Rockville (MD): The Program; 2006 [cited 2014 Jul 10]. http://dhsprogram.com/data/dataset/India_Standard-DHS_ 2006.cfm?flag=0
18. Vespa J, Lewis JM, Kreider RM. America’s families and living arrangements: 2012. Washington, DC: US Census Bureau; Aug 2013. p. 22–23 [cited 2014 Jul 10]. http://www.census.gov/prod/2013pubs/p20-570.pdf
19. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahé C, Plummer M, et al. Papillomavirus infection in rural women in southern India. Br J Cancer. 2005;92:601–6.
20. Dunne EF, Sternberg M, Markowitz LE, McQuillan G, Swan D, Patel S, et al. Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States—National Health And Nutrition Examination Survey, 2003–2006: opportunity to measure HPV vaccine impact? J Infect Dis. 2011;204:562–5. http://dx.doi.org/10.1093/infdis/jir342
21. Franceschi S, Baussano I. Naturally acquired immunity against human papillomavirus (HPV): why it matters in the HPV vaccine era. J Infect Dis. 2014;210:507–9. http://dx.doi.org/10.1093/infdis/jiu143
22. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, et al. Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer. 2011;128:2765–74. http://dx.doi.org/10.1002/ijc.25915
23. Garnett GP. An introduction to mathematical models in sexually transmitted disease epidemiology. Sex Transm Infect. 2002; 78:7–12. http://dx.doi.org/10.1136/sti.78.1.7
24. Baussano I, Garnett G, Segnan N, Ronco G, Vineis P. Modelling patterns of clearance of HPV-16 infection and vaccination efficacy. Vaccine. 2011;29:1270–7. http://dx.doi.org/10.1016/j.vaccine.2010.11.082
25. Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis. 2005;191(Suppl 1):S97–106. http://dx.doi.org/10.1086/425271
26. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol. 2010;11:249–57.http://dx.doi.org/10.1016/S1470-2045(09)70360-2
27. Soderlund-Strand A, Dillner J. High-throughput monitoring of human papillomavirus type distribution. Cancer Epidemiol Biomarkers Prev. 2013;22:242–50. http://dx.doi.org/10.1158/1055-9965.EPI-12-1003
28. Liljeros F, Edling CR, Nunes Amaral LA. Sexual networks: implications for the transmission of sexually transmitted infections. Microbes Infect. 2003;5:189–96.http://dx.doi.org/10.1016/S1286-4579(02)00058-8
29. Widdice LE, Breland DJ, Jonte J, Farhat S, Ma Y, Leonard AC, et al. Human papillomavirus concordance in heterosexual couples. J Adolesc Health. 2010;47:151–9. http://dx.doi.org/10.1016/j.jadohealth.2010.01.006
30. Kim JJ, Andres-Beck B, Goldie SJ. The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer. 2007;97:1322–8. http://dx.doi.org/10.1038/sj.bjc.6604023
31. Gravitt PE, Rositch AF, Silver MI, Marks MA, Chang K, Burke AE, et al. A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States. J Infect Dis. 2013;207:272–80. http://dx.doi.org/10.1093/infdis/jis660